Chapter 65
Community-Acquired Pneumonia
As a general rule, CAPs are present upon hospital admission or occur within the first 48 hours after admission—the latter were incubating at time of admission. In contrast, according to the American Thoracic Society’s (ATS) guidelines, health care–associated pneumonias (HCAPs) are defined as those that occur 48 hours or later after admission to a health care facility and were not incubating at the time of admission. However, pneumonias that are present upon hospital admission or shortly thereafter but occur in nonambulatory residents of a nursing home or other long-term care facility should be regarded as HCAPs and managed as such (see Chapter 14).
Clinical Diagnosis and Causes
Atypical versus Typical Pneumonia
Historically, some clinicians distinguished typical and atypical CAP based on clinical presentation. CAP caused by “atypical” organisms (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella species, and viruses) was thought to be characterized by a prior viral-like syndrome (myalgias, arthralgias, and sore throat), subacute time course, nonproductive cough, absence of pleurisy and rigors, lower fever, and absence of consolidation on auscultation compared with CAP caused by “typical” organisms (Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and gram-negative bacteria). When studied systematically, however, these characteristics were no more common in atypical than in typical pneumonias. In addition, comparing laboratory data and chest radiographs failed to discriminate between patients with typical and atypical pneumonias. Clinical demographics may give clues to the cause, but definitive diagnosis depends on laboratory and microbiologic testing to identify a specific pathogen.
Pathogens
Because initial CAP treatment is often empirical, knowledge of the most likely pathogens is vital. The causative organism may be suspected based on the patient’s risk factors or comorbid illnesses (Table 65.1). S. pneumoniae, however, remains the most common cause in all groups including those with human immunodeficiency virus (HIV). Severe recurrent pneumonias with S. pneumoniae or H. influenzae suggest an underlying immunocompromised state—for example, HIV infection or multiple myeloma. Legionella infections by non-pneumophila species may also be more common in immunosuppressed patients and warrant assessment of the patient’s immune status. Viruses may cause up to 30% of CAP. Although the most prevalent respiratory virus is influenza, others such as adenovirus, respiratory syncytial virus (RSV), and parainfluenza are also common.
TABLE 65.1
Condition | Commonly Encountered Pathogen(s) |
Alcoholism | Streptococcus pneumoniae, oral anaerobes, Klebsiella pneumoniae, Acinetobacter species, Mycobacterium tuberculosis |
Aspiration | Gram-negative enteric pathogens, oral anaerobes |
COPD or smoking | Haemophilus influenzae, Pseudomonas aeruginosa, Legionella species, S. pneumoniae, Moraxella catarrhalis, Chlamydophila pneumonia |
Cough for 12 weeks with whoop or posttussive vomiting | Bordetella pertussis |
Endobronchial obstruction | Anaerobes, S. pneumoniae, H. influenzae, Staphylococcus aureus |
Exposure to bat or bird droppings | Histoplasma capsulatum |
Exposure to birds | Chlamydophila psittaci (if poultry: avian influenza) |
Exposure to farm animals or parturient cats | Coxiella burnetii (Q fever) |
Exposure to rabbits | Francisella tularensis |
HIV infection (early) | S. pneumoniae, H. influenzae, Mycobacterium tuberculosis |
HIV infection (late) | The pathogens listed for early infection plus Pneumocystis jiroveci, Cryptococcus, Histoplasma, Aspergillus, atypical mycobacteria (especially Mycobacterium kansasii), P. aeruginosa, H. influenza |
Hotel or cruise ship stay in previous 2 weeks | Legionella species |
In context of bioterrorism | Bacillus anthracis (anthrax), Yersinia pestis (plague), Francisella tularensis (tularemia) |
Influenza active in community | Influenza, S. pneumoniae, Staphylococcus aureus, H. influenzae |
Injection drug use | S. aureus, anaerobes, M. tuberculosis, S. pneumoniae |
Lung abscess | CA-MRSA, oral anaerobes, endemic fungal pneumonia, M. tuberculosis, atypical mycobacteria |
Neutropenia | S. pneumoniae, gram-negative bacilli (especially, Pseudomonas aeruginosa) |
Nursing home residents∗ | S. pneumoniae, gram-negative bacilli (especially, Klebsiella pneumoniae), influenza A or B, S. aureus, oral anaerobes, M. tuberculosis |
Solid organ transplant recipients > 3 months after transplant | S. pneumonia, H. influenza, Legionella species, Pneumocystis jiroveci, Cytomegalovirus |
Structural lung disease (e.g., bronchiectasis) | Pseudomonas aeruginosa, Burkholderia cepacia, S. aureus |
Travel to or residence in Southeast and East Asia | Burkholderia pseudomallei, avian influenza, SARS |
Travel to or residence in southwestern United States | Coccidioides species, Hantavirus |
Young adults (age < 30) | Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae |
∗Pneumonia in nonambulatory residents of nursing homes and other long-term care facilities should be considered a health care–associated pneumonia (HCAP) as described in Chapter 14.
Adapted from Mandell LA, Wunderink RG, Anzueto A, et al: Infectious Diseases Society of America/American Thoracic Society consensus guideline on the management of community-acquired pneumonia in adults. Clin Infect Dis 44:S27-S72, 2007.
Diagnostic Evaluation
Gram Stain and Culture of Sputum
The clinical value of a sputum Gram stain and culture depends largely on the quality of the sputum specimen. Having > 25 polymorphonuclear neutrophils and < 10 squamous epithelial cells per low-power field can determine whether the sputum is an adequate sample from the lower respiratory tract. Prior antibiotic therapy decreases the usefulness of sputum cultures, because the chance of isolating an organism from sputum decreases by up to 50% after just one to two doses of antibiotic. Bronchoscopy and bronchoalveolar lavage often increase the yield of Gram stain and culture but are usually reserved for patients who do not respond to initial empirical antibiotics, are critically ill, or may harbor resistant or uncommon organisms.